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Destructive Effects of Prenatal WIN 55212-2 Exposure on Central 
Nervous System of Neonatal Rats 
Mohammad Shabani PhD1, Kouros Divsalar2, Mahyar Janahmadi PhD3 
 
Abstract 
Background: Cannabinoid, particularly hashish and WIN 55212-2 (WIN), consumption during 
embryonic period may affect fetal growth, and the development of motor functioning, memory and 
cognitive functions. Therefore, the present study aimed to evaluate the effects of WIN 55212-2 during 
embryonic period on behavioral responses, as well as tissue and memory changes among neonatal rats. 
Methods: WIN treated groups subcutaneously received daily doses of 0.5 or 1 mg/kg WIN suspended in 
1% Tween-80-saline (1 ml/kg) from days 5 to 20 of pregnancy. The vehicle group received 1% 
Tween-80-saline from days 5 to 20 of pregnancy. Three, five and seven weeks after birth, the effects of 
maternal WIN consumption on infants' body weight, mortality, histological changes, motor 
functioning, and memory function were assessed. 
Findings: Prenatal WIN consumption was associated with atrophy of cerebellum cortex in granular 
and Purkinje cells layers. WIN treatment of pregnant rats produced a significant decrease in the 
rearing frequency of the offspring, but significantly increased the grooming frequency at 22, 36 and 50 
days of age. During the acquisition trials, approach latencies were not significantly different between 
all groups of rats (50 days old). When the trial was repeated 24 hours and seven days later (retention 
trial), the avoidance latencies of the WIN-exposed group were significantly shorter than those of the 
control and vehicle animals. The mortality percent was increased significantly and litter size was 
decreased significantly in WIN (1 mg/kg) treated rats compared to the control, vehicle and WIN  
(0.5 mg/kg) treatment groups. 
Conclusion: These findings suggested that prenatal exposure to WIN probably induces long-term 
alterations in histological, motor functioning, and learning and memory parameters. 
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Introduction  
Cannabis derivatives such as hashish and 
marijuana are widely consumed for medical 
and recreational purposes, and also in some 
religions.1,2 In the late 20th century, most 
Western governments banned the medical use 
of cannabis. This decision might have been 
raised result of believing cannabis to be a 
dangerous and risky drug for mental and 
physical health. However, this view has 
significantly changed lately and efforts have 
been made to legalize and remove the legal 
sanctions of using medical and therapeutic 
properties of cannabis.1,2 Cannabinoids are 
greatly consumed in Western communities 
particularly by women at the reproductive age 
and during pregnancy. Human and animal 
researches have shown that cannabinoids easily 
cross the placental barrier and transmit to the 
infant through breast milk. Due to the effects 
they can have on fetal growth, marijuana and 
hashish consumption during the embryonic 
period causes problems in health.1,3-6 
Consumption of such drugs during the 
embryonic period has a significant impact on 
several neurotransmitter systems including 
dopaminergic, serotonergic, gamma-
Aminobutyric acid (GABA)-ergic, 
glutamatergic and opioidergic systems. They 
can thus cause major and long-term changes in 
behavioral patterns.1-7 The cannabinoid system 
has a strong modulatory action on synaptic 
transmission in the mammalian brain. 
Endogenous cannabinoids such as anandamide 
can inhibit the release of glutamate and GABA 
in large areas of brain including the cerebellum, 
hippocampus and cerebral cortex.8-11 This 
modulatory role is applied by the cannabinoid 
receptors type I and II which are 
presynaptically accumulated on the axonic 
structure in the central nervous system (CNS), 
particularly in cerebellum and 
hippocampus.11,12 Mammalian cerebellar cortex 
is one of the CNS regions with very large 
density of cannabinoid receptors type I.3 
Density and differentiation of cannabinoid 
receptors in brain in different stages of growth 
and development before and after birth and 
reflection of this differentiation in adulthood or 
maturity period suggest the likelihood of a 
particular vulnerability in long-term 
consumption of cannabis during certain phases 
of growth.1 Adult animals exposed to 
cannabinoid agonists during their pregnancy or 
infancy suffer from stable changes in behavioral 
tests such as behaviors in animal mating, 
learning ability, sensitivity to pain, sexuality 
and social behavior as well as neuroendocrine 
abnormalities.13-17 Recent studies have shown 
that cannabis consumption is associated with 
increased irritability, impaired memory and 
learning, ataxia and defects in making decisions 
about future life.18,19 According to what we 
know, there has been very few behavioral and 
histological studies identifying the effects of 
chronic cannabinoid consumption on the fetus 
of pregnant mothers. Due to presence of 
cannabinoid receptors on synapses in the 
cerebellar cortex and hippocampus, 
consumption of exogenous agonists will 
probably interfere with the normal process of 
signaling. Particularly, the probable effects of 
these agonists on memory process, balance, 
motor activity, and functioning can be taken 
into account. Therefore, the present study 
aimed to review the effects of exogenous 
cannabinoid WIN 55212-2 on the behavioral 
responses of the embryonic period, histological 
changes, and memory of neonatal rats. WIN was 
selected due to its high tendency and affinity to 
connect to cannabinoid receptors. It can also 
mimic most of marijuana and hashish effects.7,19 
 
Methods 
Study Design and Methods: 
In this study, female primiparous Wistar rats, 
weighed 200-250 grams, were used. The 
animals were provided by the Animal 
Reproduction and Breeding Center of Pasteur 
Institute. They were kept in a 12/12 light/dark 
cycle at 20-22°C in animal rooms of Shahid 
Beheshti School of Medicine, Tehran, Iran. They 
had easy access to food and water. Two female 
and one male rats were placed in a cage for 
mating in the last hours of the afternoon. 
Vaginal smear was performed the next morning 
at 9. The day of observing sperm was 
considered as day zero. The pregnant rats were 
randomly divided into control, vehicle and 
WIN treated (at least 8 rats in each group) 
groups. The pregnant rats in daily treatment 
groups received 0.5 or 1 ml/kg WIN powder 
(Sigma) from fifth to twentieth days of 
pregnancy (these doses were according to the 
previous studies).7,19 In the treatment group, the 
drug was dissolved in Tween 80 and saline 
solution (1% Tween/saline) and 
subcutaneously injected to the rats (1 ml/kg). 
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The vehicle group on the other hand was 
subcutaneously injected with 1% Tween/saline 
alone (1 ml/kg). In order to prevent the effect 
of circadian rhythm on animals, all the tests 
were conducted in daylight between 8 A.M. to 4 
P.M. In order to make rats accustomed to 
laboratory conditions, male neonates of all the 
groups were transferred to the laboratory 1 
hour before starting the tests. 
 
Histological Researches 
The male neonates of rats in the control, vehicle 
and WIN groups were deeply anesthetized and 
killed at the fifth week after birth using ether 
vapor. Thereafter, their heads were cut off and 
their cerebellum was sunk in formalin solution 
in an appropriate time for better fixing. In the 
next stage, cerebellar vermis tissue of the 
control and WIN groups were fixed and 
cryopreserved in a fixation solution plus 
sucrose overnight. The next day, the tissues 
were cut at a thickness of 25 micrometers. In 
order to evaluate pathologic changes, the slices 
were stained by Fluoro-Jade (a perfect 
fluorescein marker to diagnose degenerated 
neurons).20,21 
 
Behavioral Studies 
Open-field behavioral test using EthoVision 
video tracking system: 
Open-field test was used to assess motor 
behaviors of animals at the end of the third, 
fifth and seventh weeks after birth (at least 15 
young rats in each group). EthoVision software 
is a video detector system for automation of 
behavioral tests. It performs all stages from 
designing the test to analyzing the obtained 
data. It thus can be used for most behavioral 
tests in a wide in vitro range. The most general 
application of EthoVision is to measure 
behavioral impacts of drugs, treatments, and 
surgeries. In addition, it is increasingly used for 
behavioral phenotype of genetically modified 
rats. This device allows monitoring many social 
reactions tests. EthoVision Pro was used for the 
tests of the present study in which the 
behaviors of rats were detected in 16 areas. In 
order to do so, each rat was put in the center of 
a defined area and their motor behaviors were 
recorded through a camera for five minutes. 
The open-field space was cleaned and dried 
with alcohol between every two tests.22 
Passive-avoidance learning test: 
In this test, Shuttle Box Device was used. The  
device consisted of two dark and light 
compartments of equal size with a controllable 
door between them. At the end of the fifth week, 
in the adaptability stage, the rats (at least 15 
young rats in each group) were placed in the 
light part with their head in the dark part. After 
10 seconds, the door between the two 
compartments was opened and the rats were 
freely allowed to enter the dark part. The 
delayed time for leaving the light part was 
recorded. If this time was more than 60 seconds, 
it indicated that the rat did not desire to enter the 
dark environment. Such rats were excluded from 
the study. Two hours after re-adaptability, rats 
were placed in the light compartment again. The 
learning stage was conducted similar to the 
adaptability stage. However, the door was 
immediately closed after the rats entered the 
dark compartment and the rats' paws were 
shocked (0.5 ma for 2 seconds). The rats were 
kept inside the device for 20 minutes before they 
were taken out. Two minutes later, the learning 
stage was repeated and if the rat entered the 
dark part, it was shocked. The number of times 
the rat was socked was recorded. In retrieval 
phase, avoidance responses were measured one 
and seven days after the learning stage. Each rat 
was placed in the light compartment and the 
delayed time for re-entrance into the dark 
compartment was recorded. In this stage, the 
time of entrance, staying duration and the 
number of entrance times into the dark zone 
were measured.18 
 
Statistical Data Analysis: 
The results are reported as mean ± SEM 
(standard error of the mean). In order to review 
the normal distribution of data, Kolmogorov-
Smirnov (K-S) test was conducted in each 
group. One way analysis of variance (ANOVA) 
was used to compare the motor and retrieval 
activity. Kruskal-Wallis non-parametric test 
was used for non-normally distributed data. A 
P < 0.05 indicated statistical significance. 
 
Results 
The impacts of cannabis extract consumption 
during embryonic period on reproductive 
factors: 
In this study, the effects of WIN consumption 
during embryonic period on reproductive 
factors such as pregnancy duration, the number  
of neonates, neonatal weight and the 
percentage of infant survival were assessed. In 
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analysis, the number of infants and duration of 
pregnancy were significantly less in the WIN 
1 mg/kg group compared to the control, 
vehicle, and WIN 0.5 mg/kg groups (P < 0.001)  
(Figure 1). The survival rate was also 
significantly reduced in the WIN 1 mg/kg 
group compared to other groups. In fact, most 
neonate rats died during the first days after  
birth (Figure 2). 
The WIN 1 mg/kg group was excluded 
from the study due to major changes observed 
in the reproductive and birth factors. In the 
evaluation of weights at the first day, and at the 
first to fifth postnatal weeks were significantly 
different between WIN 0.5 mg/kg group and 
control and vehicle groups only at the end of 
the first week (Table 1). 
 
 
Figure 1. Comparison of pregnancy duration and number of litter size for born rats in the studied groups; Results 
are illustrated as mean ± SEM (n = at least 8) 
***: Significant difference with the control group (P < 0.001) 
†††, ††††: Significant differences with the vehicle group (P < 0.001 and P< 0.0001, respectively) 
‡‡, ‡‡‡: Significant differences with the 0.5 mg/kg and 1 mg/kg WIN treated groups, respectively (P < 0.01 and P < 0.001, 
respectively) 
 
 
Figure 2. The survival rate of born rats in the studied groups on day 1 and at the end of first to fifth 
postnatal weeks 
(The numbers were different: from 35 neonate rats in WIN 1 mg/kg group and maximum 61 rats in the control 
group) 
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Table 1. Comparison of neonatal weights (g) in the studied groups on the first day, and at the end of the first to fifth 
postnatal weeks 
36 29 22 15 8 1 
Experimental Days 
Group 
2.58 ± 74.00 1.68 ± 44.76 0.84 ± 27.78 0.50 ± 19.11 0.22 ± 10.71 0.10 ± 5.51 Control 
1.03 ± 71.66 2.45 ± 42.04 0.63 ± 27.53 0.40 ± 18.41 0.22 ± 10.09 0.06 ± 5.23 Vehicle 
2.05 ± 69.58 1.56 ± 39.66 0.76 ± 26.08 0.39 ± 18.10 0.33 ± 9.71 *†  0.13 ± 5.50 WIN 0.5 mg/kg  
* Significant difference with the control group (P < 0.01); † Significant difference with the vehicle group (P < 0.01)  
(at least n = 30) 
 
Findings of Histological Studies: 
The effects of hashish extract consumption 
during embryonic period on cerebellar cortex: 
Fluoro-Jade staining was used to evaluate 
the destructive effects and probable pathologic 
changes on Purkinje neurons resulted by WIN 
(0.5 mg/kg) during embryonic period. The 
normal cerebellar cortex with ordered granular 
and Purkinje cells layers was observed after 
Fluoro-Jade staining in the three control, 
vehicle and treatment groups (Figure 3A). In 
WIN treated rats, the damaged areas were 
clearly detectable as black and hollow dots both 
in Purkinje cell layers and in layers containing 
granular cells. In the WIN group, Purkinje 
neurons were stained as irregular and shattered 
dots in vermis layer with high intensity. In 
addition, the apparent density of Purkinje 
neurons in this group (Figure 3B) was lower 
than the control group (Figure 3A). Therefore, 
Purkinje neuron cell body with lower density in 
the treated group was clearer (more visible) 
than Purkinje neuron cells of the control group 
with high density. 
 
Findings of Behavioral Studies: 
In the present study, in the open-field test at the 
end of the third, fifth and seventh postnatal 
weeks, the number of rearing in neonate rats 
whose mothers were treated with WIN during 
pregnancy, had a significant reduction 
compared to the control and vehicle groups 
(Figure 4A). On the other hand, grooming 
behavior had a significant increase in the WIN 
group compared to the control and vehicle 
groups, i.e. rats in the first group were often 
sitting alone in a corner grooming themselves 
and had the highest frequency of grooming 
behavior (Figure B4). 
The effects of cannabis extract consumption 
during embryonic period on memory and 
learning: 
In this study, the effects of chronic 
administration of WIN on acquisition and  
 
 
Figure 3. Figure A illustrates the order of cerebellar 
cortical layers and high density of Purkinje cells in the 
control rats (molecular layer (M), Purkinje cell layer 
(P) and granular layer (G). Figure B illustrates 
different cerebellar cortex layers 30 days after birth of 
rats treated with WIN 55212-2 during embryonic 
period. In the treated group, Purkinje neuron cells are 
irregular and shattered and with lower density than 
the control group. The red arrowhead indicates the 
places damaged and the blue arrowhead indicates cell 
bodies from healthy Purkinje cells. 
 
retrieval abilities of neonate rats whose mothers 
were treated with WIN 0.5 mg/kg during 
pregnancy were evaluated. There were no 
significant differences between the groups in 
terms of the number of times necessary for 
learning. Likewise, there were no significant 
differences between the control and vehicle 
groups in the duration and frequency of 
entrance into the dark room on days 1 and 7 
after the acquisition. However, there was a 
significant difference between WIN treated and 
vehicle groups on day 1 (P < 0.01) and day 7  
(P < 0.05) (Figures 5A and 5B). The duration of 
staying in the dark zone on day 1 after the 
acquisition increased significantly in the WIN 
treated group compared to the control group  
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(P < 0.05). However, the duration of staying in 
the dark on day 7 after the acquisition was not 
significantly different between groups  
(Figure 5C). 
 
Discussion 
Cannabinoids are the active components of  
hashish or marijuana and are their endogenous 
analogues which cause extensive central and 
peripheral effects by connecting to their 
receptors. In the past few centuries, marijuana 
and hashish used to be consumed greatly by 
women at reproductive age and during 
pregnancy.23 Human and animal studies have 
 
 
Figure 4. Comparison of the interval between rearing and grooming in the studied groups on 22, 36 and 50 
postnatal days in figures A and B, respectively (n = 8) (Values are expressed as mean ± SEM.) 
*, **, ***, **** indicate significant differences with the control group (P < 0.05, P < 0.01, P < 0.001, and P < 0.0001, respectively) 
†, ††, †††, †††† indicate significant differences with the vehicle group (P < 0.05, P < 0.01, P < 0.001, and P < 0.0001, respectively) 
 
 
 
Figure 5. Comparison of memory retrieval, the frequency of entrance into dark compartment and duration of 
staying in dark zone in the studied groups on days 1 and 7 after acquisition, and at the end of the seventh week 
after birth in Figures A, B, and C, respectively (n = 8) (Values are expressed as mean ± SEM.) 
*, **, ***, **** indicate significant differences with the control group (P < 0.05, P < 0.01, P < 0.001, and P < 0.0001, respectively) 
†, ††, ††† indicate significant differences with the vehicle group (P < 0.05, P < 0.01, and P < 0.001, respectively) 
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shown that cannabinoids easily cross the 
placental barrier and can be transmitted to 
infant through breast milk.23 Among the WIN 
55212-2 treated rats in the present study, the 
damaged areas were clearly detectable as black 
and hollow dots both in Purkinje cell layers and 
in layers containing granular cells. In this 
group, Purkinje neurons were stained as 
irregular and shattered dots in vermis layer 
with high intensity. Moreover, the apparent 
density of Purkinje neurons in this group 
(Figure 3B) was lower than the control group 
(Figure 3A). 
Consumption of marijuana particularly 
influences posterior cerebral blood circulation 
and may be considered as a risk factor for 
stroke in children. It also has acute effects such 
as dizziness, disordered balance due to 
orthostatic hypotension. It is associated with 
bradycardia and general hypotension in high 
doses. Unlike most cerebellar ischemic strokes 
which can be seen in a blood vessel, in 
cerebellar stroke resulted from marijuana, 
several blood vessels have infarction. Cerebellar 
damage due to lack of strong peripheral circuits 
in the blood circulation have higher risk for 
infarction in marijuana consumption. 
Marijuana results in vascular spasm, 
hypotension, impaired self-regulatory system, 
and vasomotor reflex and can cause infarction 
and cerebellar damage.24 Often, a large area of 
cortex and cerebellum in the brain suffers from 
atrophy in drugs, particularly cannabis and 
heroin and alcohol, abusers. Severe atrophy of 
cerebellum and frontal vermis lobe have 
specifically been reported.25 There is a high 
density of CB1 receptors at the end of axons 
which synapse with Purkinje cells. These 
receptors usually apply their effects through 
connecting to G proteins. Overexpression of 
these receptors in the cerebellum and other 
brain regions are associated with defects in 
motor control system.26-28 Chronic treatment 
with cannabinoid leads to insensitivity and 
reduction of cannabinoid receptors in brain and 
significantly increases the cyclic adenosine 
monophosphate (cAMP) levels and protein 
kinase A (PKA) activity.29 Chronic consumption 
of cannabinoids can reduce mesolimbic system 
activity and is thus considered as a high and 
significant risk factor for progression and 
development of schizophrenia in adults.30 
Change in the number of rearing is a sign of 
alterations in spontaneous motor activity and 
searching behavior of animal. On the other 
hand, changes in the number of grooming 
indicate the probable damage, obsessive 
behavior and decreased locomotor activity. 
Decreased number of rearing in the present 
study was in accordance with the results 
reported by Miller et al. who indicated chronic 
WIN consumption during pregnancy to cause 
decreased locomotor activity and seeking 
behavior of neonates after birth.31 They also 
reported reductions in two motor criteria, i.e. 
ambulation and rearing, in 
tetrahydrocannabinol (THC) consumption.31 
Meanwhile, Mereu et al. found no significant 
differences in these two parameters following 
chronic consumption of WIN during embryonic 
period at 40 and 80 days after birth compared 
to the control group. However, increased 
locomotor activity and deficits in memory 
retrieval were reported as a result of chronic 
cannabis consumption.32 Consumption of these 
substances during embryonic period can bring 
about major health problems to the fetus.3,7,9,19,23 
Pregnancy is a critical period in development of 
the nervous system. During the fetal 
development, each region, system and circuit of 
the brain develops rapidly. Therefore, any 
incomplete stage would remain 
uncompensated in the later stages. 
Subsequently, any change in the development 
of the nervous system in this period would be 
associated with deficits in CNS functioning 
including motor and cognitive activities.33 In a 
study by Masur et al., reductions in rearing, 
grooming, and the frequency of excretion were 
reported following 25 mg/kg THC 
consumption.34 Vardaris et al. evaluated the 
effects of THC by open-field and observed a 
reduction in invasive behavior.35 Navarro et al. 
found that fetal exposure to cannabis extract 
reduced motor activity in male rats. However, 
they discovered increased motor activity in 
female rats born from mothers exposed to 
hashish extract during pregnancy.36 In this 
study, WIN consumption during pregnancy 
reduced the time of entrance and increased the 
frequency of the dark zone in neonate rats at 
young ages (Figure 5). This can indicate 
impairments in the memory retrieval process 
due to the effects of CB1 cannabinoid receptor 
agonist. In learning and acquisition stages, 
there were no significant differences between 
the WIN, vehicle and control groups. Vardaris 
et al. administered THC in pregnant rats and 
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reported the active ingredient in cannabis to 
cause impairments in acquisition and retrieval 
processes in neonate rats 21 days after birth.35 
However, Miller et al. found no impacts on 
acquisition and retrieval processes after 
administration of 5 and 15 mg/kg THC.31 
Similar to the present study, Mereu et al. 
reported impairments in retrieval in neonate 
rats after cannabis consumption during 
pregnancy.32 On the other hand, Luo et al. 
discussed that due to the activation of 
calcineurin and effects on long-term 
potentiation (LTP) and long-term depression 
(LTD), cannabis can improve the induced 
impairments in memory and learning by 
chemicals.37 Hippocampus, especially in 
contortion areas and CA3, is one of the regions 
with the highest density of cannabinoid 
receptors.38 Cannabinoids consumption 
influences CB1 receptors, activates several 
signaling paths inside the cell, inhibits adenyl 
cyclase activity and voltage-dependent calcium 
channels, activates potassium channels 
(specially inward rectifier fast type), and causes 
irreversible changes on cannabinoid system in 
the body. It can thus trigger changes in 
emotional status and mood and interfer in 
short-term memory.9,39 Cannabinoid receptor 
density varies during different stages of  
growth. In long-term consumption and abuse 
of cannabis, their receptors are affected by the 
reduction of sensitivity. Such a finding has 
particularly been reported in hippocampus of 
adult rats.38 
Available evidence indicates cannabis 
consumption to make changes in morphology 
of cannabinoids in hippocampus neurons and 
to reduce the density of gray matter in 
hippocampus.40 Special imaging methods have 
proved that blood circulation in the prefrontal 
cortex and also parahippocampal activity 
during verbal memory and learning reduce 
among cannabis consumers.41,42 
 
Conclusion 
In this study, the observed changes in 
locomotor activity, learning and memory along 
with histological examinations in neonates of 
rats treated with cannabis during pregnancy 
confirmed the hypothesis of fundamental and 
long-term changes in behavioral patterns due to 
cannabis consumption. Such changes could 
have been caused by the effects of cannabis on 
neurotransmitter systems including 
dopaminergic, serotonergic, GABAergic, 
glutamatergic and opioidergic systems.1,7 
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  ﭼﻜﻴﺪه
 در آﺳﻴﺐ ﺑﺎ ﺗﻮاﻧﺪ ﻣﻲ ﺟﻨﻴﻨﻲ، دوره ﻃﻮل در NIW 21255 - 2 )NIW(و  ﺣﺸﻴﺶ ﺟﻤﻠﻪ از ﻛﺎﻧﺎﺑﻴﻨﻮﻳﻴﺪﻫﺎ ﻣﺼﺮف :ﻣﻘﺪﻣﻪ
 دوره ﻣﺼﺮف اﺛﺮ ﺑﺮرﺳﻲ ﺑﺎ ﻫﺪف، ﺣﺎﺿﺮ ﻣﻄﺎﻟﻌﻪ .ﺑﺎﺷﺪ ﻫﻤﺮاه ﻣﺮﻛﺰي اﻋﺼﺎب ﺳﻴﺴﺘﻢ ﻋﻤﻠﻜﺮد در ﻧﻘﺺ ﺟﻨﻴﻦ و رﺷﺪ روﻧﺪ
  .اﻧﺠﺎم ﺷﺪ ﺻﺤﺮاﻳﻲ ﻫﺎي ﻣﻮش ﻧﻮزادان ﺣﺎﻓﻈﻪ و ﺑﺎﻓﺘﻲ ﺗﻐﻴﻴﺮات رﻓﺘﺎري، ﻫﺎي ﭘﺎﺳﺦ روي NIW 21255 - 2 ﺟﻨﻴﻨﻲ
 درﻳﺎﻓﺖ ﺣﺎﻣﻠﮕﻲ 02 ﺗﺎ 5 روز از NIW ﻛﻴﻠﻮﮔﺮم ﺑﺮ ﮔﺮم ﻣﻴﻠﻲ 1 ﻳﺎ 0/5 روزاﻧﻪ ،درﻣﺎن ﮔﺮوه ﺻﺤﺮاﻳﻲ ﻫﺎي ﻣﻮش :ﻫﺎ روش
 ،وزن ﻣﻴﺮ، و ﻣﺮگ ﻣﻴﺰان ﺮﺑ ﺟﻨﻴﻨﻲ ﻣﺮﺣﻠﻪ در NIW اﺛﺮ ﺗﻮﻟﺪ، از ﭘﺲ ﻫﻔﺘﻢ و ﭘﻨﺠﻢ ﺳﻮم، ﻫﺎي ﻫﻔﺘﻪ اﻧﺘﻬﺎي در ﻛﺮدﻧﺪ و
  .ﮔﺮﻓﺖ ﻗﺮار ﺑﺮرﺳﻲ ﻣﻮرد ﻧﻮزادان ﺣﺎﻓﻈﻪ و ﺣﺮﻛﺘﻲ رﻓﺘﺎر ﺑﺎﻓﺘﻲ، ﺗﻐﻴﻴﺮات
 در. ﺷﺪ ﻫﺎ ﻣﻮش ﻧﻮزادان ﻣﺨﭽﻪ وﮔﺮاﻧﻮﻻر ﭘﻮرﻛﻨﮋ ﻫﺎي ﻻﻳﻪ ﺗﺨﺮﻳﺐ ﺑﺎﻋﺚ ،ﺣﺎﻣﻠﮕﻲ ﻃﻮل دوران در NIW ﻣﺼﺮف :ﻫﺎ ﻳﺎﻓﺘﻪ
 و gniraeR ﺗﻌﺪاد در داري ﻣﻌﻨﻲ ﻛﺎﻫﺶ ﺗﻮﻟﺪ، از ﭘﺲ ﻫﻔﺘﻢ و ﭘﻨﺠﻢ ﺳﻮم، ﻫﺎي ﻫﻔﺘﻪ اﻧﺘﻬﺎي در ﺣﺮﻛﺘﻲ ﻓﻌﺎﻟﻴﺖ ﺑﺮرﺳﻲ
. ﮔﺮدﻳﺪ ﻣﺸﺎﻫﺪه ﺣﻼل و ﺷﺎﻫﺪ ﻫﺎي ﮔﺮوه ﺑﻪ ﻧﺴﺒﺖ NIW ﺑﺎ درﻣﺎن ﺗﺤﺖ ﮔﺮوه gnimoorG ﺗﻌﺪاد در داري ﻣﻌﻨﻲ اﻓﺰاﻳﺶ
 ﻧﻮزادان در اﻛﺘﺴﺎب از ﭘﺲ 7 و 1 روز در ﺗﺎرﻳﻚ اﺗﺎق ﺑﻪ ورود زﻣﺎن و دﻓﻌﺎت ﺗﻌﺪاد در داري ﻧﻴﺰ ﻣﻌﻨﻲ ﻛﺎﻫﺶ و اﻓﺰاﻳﺶ
 در داري ﻣﻌﻨﻲ ﻛﺎﻫﺶ. وﺟﻮد داﺷﺖ ﺣﻼل و ﺷﺎﻫﺪ ﮔﺮوه ﺑﻪ ﻧﺴﺒﺖ ﺑﻮدﻧﺪ، NIW درﻣﺎن ﺗﺤﺖ ﺟﻨﻴﻨﻲ دوره ﻛﻪ ﻫﺎﻳﻲ ﻣﻮش
داد  ﻧﺸﺎن NIW0/5 gk/gm و ﺣﻼل ﺷﺎﻫﺪ، ﮔﺮوه ﺑﻪ ﻧﺴﺒﺖ  NIW1 gk/gm ﮔﺮوه ﺣﺎﻣﻠﮕﻲ دوره ﻃﻮل و ﻧﻮزادان ﺗﻌﺪاد
  .ﻳﺎﻓﺖ داري ﻣﻌﻨﻲ اﻓﺰاﻳﺶ ﻣﻴﺮ و ﻣﺮگ درﺻﺪ در ﺣﺎﻟﻲ ﻛﻪ؛ (P < 0/100)
 ﺑﻪ آﺳﻴﺐ ﻣﻮﺟﺐ و ﺷﺪه ﻣﻐﺰ ﻫﺎي ﺳﻠﻮل ﺗﺨﺮﻳﺐ ﺑﺎﻋﺚ ﺗﻮاﻧﺪ ﻣﻲ ﺣﺎﻣﻠﮕﻲ ﻃﻲ در ﻛﺎﻧﺎﺑﻴﻨﻮﻳﻴﺪﻫﺎ از اﺳﺘﻔﺎده ﺷﺎﻳﺪ :ﮔﻴﺮي ﻧﺘﻴﺠﻪ
  .ﺷﻮد ﻧﻮزادان ﻳﺎدﮔﻴﺮي و آوري ﺑﻪ ﺧﺎﻃﺮ ﺗﻮان و ﺣﺮﻛﺖ ﻛﻨﺘﺮل ﺟﻤﻠﻪ از ﻣﺮﻛﺰي اﻋﺼﺎب ﺳﻴﺴﺘﻢ ﻋﻤﻠﻜﺮد
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